Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOSPain and IKDCfunction... .
Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOSPain and IKDCfunction... .
Regenerative Solutions revenue up 41% with Integrity™ Implant System ahead of expectations and continued strong Hyalofast® growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 ... .
A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com ... For more information about Anika, please visit www.anika.com. ANIKA, ANIKA THERAPEUTICS, ...
Anika Reports Topline Results from U.S ... Based on the totality of the data, Anika plans to file the final PMA module in H2 2025. BEDFORD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc ... Anika Therapeutics Inc.